Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: Feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease

Journal of Comparative Neurology

Volumn 442, Issue 4, 2002, Pages 320-330

  Collier, Timothy J ^a   Sortwell, Caryl E ^a   Elsworth, John D ^b   Taylor, Jane R ^b   Roth, Robert H ^b   Sladek, John R ^c   Redmond, D Eugene ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c The Chicago Medical College   (United States)

Author keywords

Caudate nucleus; Dopamine; Nonhuman primate; Putamen; Transplant

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN GRAFT; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; IMPLANT; MALE; MESENCEPHALON; MONKEY; NERVE DEGENERATION; NERVE GRAFT; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

ANIMALS; AXONS; BRAIN TISSUE TRANSPLANTATION; CELL DIFFERENTIATION; CERCOPITHECUS AETHIOPS; DOPAMINE; GRAFT SURVIVAL; HOMOVANILLIC ACID; IMMUNOHISTOCHEMISTRY; MALE; NEOSTRIATUM; NERVE REGENERATION; NEURITES; NEURONS; PARKINSONIAN DISORDERS; RECOVERY OF FUNCTION; STEM CELL TRANSPLANTATION; STEM CELLS; SUBSTANTIA NIGRA; TREATMENT OUTCOME; TYROSINE 3-MONOOXYGENASE;

EID: 0037147762     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.10108     Document Type: Article

References (72)

1. Estimation of nuclear population from microtome sections
2. The functional anatomy of basal ganglia disorders
3. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions
4. Ret receptor tyrosine kinase immunoreactivity is altered in glial cell linederived neurotrophic factor responsive neurons following lesions of the nigrostriatal and septohippocampal pathways
5. Simultaneous intrastriatal and intranigral dopaminergic grafts in the parkinsonian rat model: Role of the intranigral graft
6. Transplantation of fetal nigral cells reverses the increase of preproenkephalin mRNA levels in the rat striatum caused by 6-OHDA lesion of the dopaminergic nigrostriatal pathway: A quantitative in situ hybridization study
7. Transient behavioral recovery in hemiparkinsonian primates after adrenal medullary autografts
8. Expression of acidic and basic fibroblast growth factors in the substantia nigra of the rat, monkey, and human
9. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus
10. Comparison of adrenal medullary, carotid body, and PC12 cell grafts in 6-OHDA lesioned rats
11. GDNF mRNA expression in normal postnatal development, aging and in weaver mutant mice
12. Adrenal medullary grafts promote recovery of striatal dopaminergic fibers in MPTP-treated mice
13. Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: Differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels
14. Temporal and spatial increase of astroglial basic fibroblast growth factor synthesis after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine neurons
15. Dendritic release of dopamine in the substantia nigra
16. Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat
17. Therapeutic potential of nerve growth factors in Parkinson's disease
18. Limited recovery of striatal dopaminergic fibers by adrenal medullary grafts in MPTP-treated aging mice
19. Primate models of movement disorders of basal ganglia origin
20. Effects of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF
21. Symptomatic and asymptomatic 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated primates: Biochemical changes in striatal regions
22. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment
23. The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia
24. Adrenal medullary autografts into the basal ganglia of Cebus monkeys: Injury-induced regeneration
25. Intracerebral adrenal medulla grafts: A review
26. Cells that express brain-derived neurotrophic factor mRNA in the developing postnatal rat brain
27. Brain-derived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons
28. Release of dopamine from dendrites in rat substantia nigra
29. Adrenal medullary autografts into the basal ganglia of Cebus monkeys: Graft viability and fine structure
30. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain
31. Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson's disease
32. Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, ultrastructural, and metabolic studies
33. Increase of striatal methionine enkephalin content following lesion of the nigrostriatal dopaminergic pathway in adult rats and reversal following the implantation of embryonic dopaminergic neurons: A quantitative immunohistochemical analysis
34. Altered succinate dehydrogenase activity of basal ganglia following damage to mesotelencephalic dopaminergic projection
35. Reconstruction of the striato-nigro-striatal circuitry by simultaneous double dopaminergic grafts: A tracer study using Fluoro-Gold and horseradish peroxidase
36. Reconstruction of the nigrostriatal pathway by simultaneous intrastriatal and intranigral dopaminergic transplants
37. Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system
38. Intrastriatal mesencephalic grafts affect neuronal activity in basal ganglia nuclei and their target structures in a rat model of Parkinson's disease
39. Intranigral fetal dopamine grafts induce behavioral compensation in the rat Parkinson model
40. Fetal nigral transplantation as a therapy for Parkinson's disease
41. Forelimb akinesia in the rat Parkinson model: Differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test
42. An immortalized, type-1 astrocyte of mesencephalic origin source of a dopaminergic neurotrophic factor
43. Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF
44. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient
45. Long-term evaluation of hemiparkinsonian monkeys after adrenal autografting or cavitation alone
46. Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion
47. Effects of graft-derived dopaminergic innervation on the target neurons of patch and matrix compartments of the striatum
48. Dopamine receptor interactions: Some implications for the treatment of Parkinson's disease
49. PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model
50. Regional and cellspecific expression of GDNF in rat brain
51. Expression of neurotrophins by midbrain dopaminergic neurons
52. Regional expression of transforming growth factor-alpha mRNA in the rat central nervous system
53. Dopaminergic neurons in rat ventral midbrain express brain derived neurotrophic factor and neurotrophin-3 mRNAs
54. Increased proenkephalin mRNA levels in the rat neostriatum following lesion of the ipsilateral nigrostriatal dopamine pathway with 1-methyl-4phenylpyridinium ion (MPP+): Reversal by embryonic nigral dopamine grafts
55. Optimal survival of grafted mesencephalic dopamine (DA) neurons is attained from tissue taken during neurogenesis of the substantia nigra in non-human primate
56. Techniques for neural transplantation in non-human primates
57. Expression of GDNF mRNA in rat and human nervous tissue
58. Mesencephalic type 1 astrocytes rescue dopaminergic neurons from death induced by serum deprivation
59. Astrocyte-dependent and -independent phases of the development and survival of rat embryonic day 14 mesencephalic, dopaminergic neurons in culture
60. Behavioral effects of MPTP administration in the vervet monkey: A primate model of Parkinson's disease
61. Sham surgery does not ameliorate MPTP-induced behavioral deficits in monkeys
62. Severe long-term 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus)
63. High molecular weight basic fibroblast growth factor-like protein is localized to a subpopulation of mesencephalic dopaminergic neurons in the rat brain
64. Characterization of a multicomponent GDNF receptor
65. Functional receptor for GDNF encoded by the c-ret proto-oncogene
66. Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS
67. Preliminary report on adrenal medullary grafting and cografting with sural nerve in the treatment of hemiparkinsonian monkeys
68. Neurturin and glial cell line-derived neurotrophic factor receptor beta (GDNFR-beta), novel proteins related to GDNF and GDNF-alpha with specific cellular patterns of expression suggesting roles in the developing and adult nervous system and in peripheral organs
69. Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants
70. Immunocytochemical localization of trkB in the central nervous system of the adult rat
71. Intranigral transplants of fetal ventral mesencephalic tissue attenuate D1-agonist induced rotational behavior